KellySushenWuMD

PubMed

• Loss of DAB2IP in RCC cells enhances their growth and resistance to mTOR-targeted therapies.
  Zhou, J.,Luo, J.,Wu, K.,Yun, E. J.,Kapur, P.,Pong, R. C.,Du, Y.,Wang, B.,Authement, C.,Hernandez, E.,Yang, J.,Xiao, G.,Cha, T. L.,Wu, H. C.,Wu, D.,Margulis, V.,Lotan, ...> ;Oncogene. 2016 Feb 16
• ACP5, a direct transcriptional target of FoxM1, promotes tumor metastasis and indicates poor prognosis in hepatocellular carcinoma.
  Xia L, Huang W, Tian D, Chen Z, Zhang L, Li Y, Hu H, Liu J, Chen Z, Tang G, Dou J, Sha S, Xu B, Liu C, Ma J, Zhang S, Li M, Fan D, Nie Y, Wu K> ;Oncogene. 2014-03-13
• The role of DAB2IP in androgen receptor activation during prostate cancer progression.
  Wu, K.,Liu, J.,Tseng, S. F.,Gore, C.,Ning, Z.,Sharifi, N.,Fazli, L.,Gleave, M.,Kapur, P.,Xiao, G.,Sun, X.,Oz, O. K.,Min, W.,Alexandrakis, G.,Yang, C. R.,Hsieh, C. L.,W...> ;Oncogene. 2013 Apr 22
• Cross-talk between endothelial cells and tumor via delta-like ligand 4/Notch/PTEN signaling inhibits lung cancer growth.
  Ding X, Ding J, Wu K, Wen W, Liu C, Yan H, Chen C, Wang S, Tang H, Gao C, Guo L, Cao D, Li Z, Feng G, Wang H, Xu Z> ;Oncogene. 2012-06-07
• Tissue and tumor expression of a cell surface glycoprotein complex containing an integral membrane glycoprotein activator of p185neu.
  Wu K, Salas PJ, Yee L, Fregien N, Carraway KL> ;Oncogene. 1994-11-01
• Join now to see all